LON:ONT - Oxford Nanopore Technologies Stock Price Target and Predictions

Oxford Nanopore Technologies Limited develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an alternative lab equipment. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data, as well as Q-Line systems to run nanopore-based sequencing in regulated environments. The company sells its products online. Oxford Nanopore Technologies Limited was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. The company was incorporated in 2005 and is based in Oxford, the United Kingdom.